Krystal Biotech Chief Commercial Officer Andrew Orth receives $9M in 2021
Krystal Biotech reports 2021 executive compensation
By ExecPay News
Published: April 7, 2022
Krystal Biotech reported fiscal year 2021 executive compensation information on April 7, 2022.
In 2021, four executives at Krystal Biotech received on average a compensation package of $6.2M, a 457% increase compared to previous year.
Average pay of disclosed executives at Krystal Biotech
Andrew C. Orth, Chief Commercial Officer, received $9M in total. 95% of Orth's compensation, or $8.6M, was in option awards. Orth also received $131K in bonus, $269K in salary, as well as $9.9K in other compensation.
Krish S. Krishnan, Chief Executive Officer, received a compensation package of $7.4M, which increased by 862% compared to previous year. 44% of the compensation package, or $3.2M, was in stock awards.
Suma M. Krishnan, President, R&D, earned $5.1M in 2021, a 750% increase compared to previous year.
Kathryn A. Romano, Chief Accounting Officer, received $3.5M in 2021, which increases by 76% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 7, 2022.